Literature DB >> 6889620

Purification and characterization of a high molecular weight eosinophil chemotactic factor from Schistosoma japonicum eggs.

M Owhashi, A Ishii.   

Abstract

A high m.w. eosinophil chemotactic factor (ECF-SjE) was isolated and purified from a soluble egg antigen preparation (SEA) of Schistosoma japonicum by gel filtration on Sephacryl S-200, anion-exchange chromatography on DE52, and isoelectric focusing. ECF-SjE had a m.w. of more than 900,000 and an isoelectric point of 4.1. It contained 40% (w/w) sugar residues and bound to concanavalin A (Con A). The chemotactic activity of ECF-SjE was heat stable (100 degrees C, 60 min) and resistant to pronase digestion, but was destroyed by periodate oxidation. IgG antibody to ECF-SjE was detected in the serum of a rabbit infected with S. japonicum, demonstrating the antigenic nature of ECF-SjE. The antigenicity of ECF-SjE was also sensitive to periodate oxidation. Thus, ECF-SjE is a glycoprotein or proteoglycan from the eggs of S. japonicum, and the sugar chain is important for the expression of chemotactic and antigenic activities. However ECF-SjE differs from the major allergenic components of S. japonicum (JEAL) in m.w. and isoelectric point. A low m.w. eosinophil chemotactic factor was also detected in SEA. Together they are proposed to have a role in the direct accumulation of eosinophils in the egg-induced granulomas in S. japonicum infection.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6889620

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Eosinophil chemotactic lymphokine produced by egg-associated granulomas in murine schistosomiasis japonicum.

Authors:  M Owhashi; H Maruyama; Y Nawa
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  Granulocyte-macrophage colony-stimulating factor produced by splenic T lymphocytes of mice infected with Schistosoma japonicum.

Authors:  M Owhashi; Y Nawa
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

3.  Extramedullary eosinophilopoiesis in the liver of Schistosoma japonicum-infected mice, with reference to hemopoietic stem cells.

Authors:  H Maruyama; A Higa; M Asami; M Owhashi; Y Nawa
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

4.  Chemotactic activity of soluble extract of Schistosoma japonicum eggs for human and monkey eosinophils.

Authors:  Y Horii; H Matsuoka; M Owhashi
Journal:  Z Parasitenkd       Date:  1986

Review 5.  The eosinophil leukocyte: controversies of recruitment and function.

Authors:  L P Bignold
Journal:  Experientia       Date:  1995-04-15

6.  Granulocyte-macrophage colony-stimulating factor enhances the production of eosinophil chemotactic lymphokine by egg-associated granulomas of Schistosoma japonicum-infected mice.

Authors:  M Owhashi; H Maruyama; Y Nawa
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  Eosinophils utilize multiple chemokine receptors for chemotaxis to the parasitic nematode Strongyloides stercoralis.

Authors:  Louis H Stein; Kevin M Redding; James J Lee; Thomas J Nolan; Gerhard A Schad; James B Lok; David Abraham
Journal:  J Innate Immun       Date:  2009-08-05       Impact factor: 7.349

8.  Mechanisms of eosinophil accumulation around eggs of Schistosoma japonicum: role of two purified components, allergen and eosinophil chemotactic factor, from soluble egg antigens measured on sensitized guinea pig skin.

Authors:  Y Horii; M Owhashi; A Ishii
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

9.  Schistosoma japonicum soluble egg antigens activate naive B cells to produce antibodies: definition of parasite mechanisms of immune deviation.

Authors:  T Yamashita; T Watanabe; S Saito; Y Araki; F Sendo
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

10.  Granulocyte-macrophage colony-stimulating factor in the sera of Schistosoma japonicum-infected mice.

Authors:  M Owhashi; Y Nawa
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.